| 43.29 Delayed Data As of Sep 20 |  +0.23 / +0.53%Today’s Change | 31.56 Today|||52-Week Range 43.84 | +22.50% Year-to-Date |
| BAX or BSX: Which Is the Better Value Stock Right Now? Sep 13 / Zacks.com - Paid Partner Content | IoMT Becomes the Buzzword in New Age MedTech Investing Sep 13 / Zacks.com - Paid Partner Content |
| Previous close | 43.06 |
| Today’s open | 43.29 |
| Day’s range | 42.85 - 43.40 |
| Volume | 8,006,073 |
| Average volume (3 months) | 6,205,953 |
| Market cap | $58.3B |
| Earnings growth (last year) | +1,412.50% |
| Earnings growth (this year) | +6.28% |
| Earnings growth (next 5 years) | +10.40% |
| Revenue growth (last year) | +8.57% |
| P/E ratio | 43.7 |
| Price/Sales | 5.04 |
| Price/Book | 6.64 |
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | -2.83 | -1.10% |
| BAXBaxter International... | -0.06 | -0.07% |
| ZBHZimmer Biomet Holdin... | +2.36 | +1.69% |
| TFXTeleflex Inc | +2.10 | +0.61% |
| Next reporting date | October 23, 2019 |
| EPS forecast (this quarter) | $0.38 |
| Annual revenue (last year) | $9.8B |
| Annual profit (last year) | $1.7B |
| Net profit margin | 17.01% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer Michael F. Mahoney |
Executive Vice President- Operations Edward Mackey |
Corporate headquarters Marlborough, Massachusetts |
